Log in
Email Address
Password
Forgot your password?
Not Registered?

Featured Tenants

 cfai

The Centre for Advanced Instrumentation at the NETPark Research Institute collaborates with observatories world-wide in the construction, commissioning and exploitation of innovative hi-tech instruments for optical and infrared astronomy. Key research areas are advanced spectroscopy, adaptive optics, applied optics, low light level detectors and precision engineering/metrology.

Click here to learn more about Centre for Advanced Instrumentation

Featured Opportunity
An Improved Microgripper for Cell Manipulation

There is a growing need for individual cell manipulation in a wide range of research applications including stem cell sorting, gene and molecular delivery, cellular diagnostics, and single cell-based assays. When compared with data-averaging over a cell population, direct physical cell manipulation offers the researcher much more precise selection and understanding of cell properties.


For further information click here

Polls



CDEP logo

cddc   European Union emblem

Prospects for Aids vaccine 'bleak'
Bookmark and Share Add This     Email notification Email a Friend    print Printable version

Prospects for Aids vaccine 'bleak'

2008-04-25
Newsfeed

Scientific consensus on the prospect for development of an effective preventive Aids vaccine is bleak, according to researchers.

Scientific consensus on the prospect for development of an effective preventive Aids vaccine is bleak, according to researchers.

The study offered additional credibility to the recent call by Aids Healthcare Foundation to halt US government funding of repeatedly failing Aids vaccine research, which for more than 20 years has shown few results other than how not to develop a vaccine.

In a poll of more than 35 scientists in Britain and the US, nearly two-thirds believed that an HIV vaccine will not be developed within the next 10 years.

AHF's call to halt taxpayer funding of vaccine research first came last month in an article in the Baltimore Sun published two days before a summit to discuss HIV vaccine funding in the wake of a string of recent clinical trial failures.

These included Merck's latest vaccine candidate, which was pulled from human clinical trials when it not only failed as a vaccine but was found to endanger lives by increasing the likelihood that participants would contract the virus.

"The results of this poll clearly show scientific consensus on Aids vaccine development is gloomy at best," said Michael Weinstein, president of Aids Healthcare Foundation.

Copyright © The Press Association 2008


Add Comment | View All Comments (0)


Related Links